Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Luminal toxins and harmful substances in the gastrointestinal tract encompass a diverse array of pathogenic molecules and metabolic waste products found within the gut interior. This category includes bacterial exotoxins (e.g., Clostridioides difficile toxins A and B), endogenous metabolites like bile acids, and exogenous harmful agents such as heavy metals or ingested poisons (StatPearls, 2023). These substances contribute to disease by damaging the intestinal epithelial lining, triggering inflammatory responses, or causing systemic toxicity upon absorption (PubMed, PMID: 31430948). Therapeutic management typically involves the use of oral adsorbents, such as activated charcoal, or specific sequestrants like bile acid binders that physically trap these substances to facilitate their fecal excretion (Mayo Clinic, 2024). In specific cases, targeted therapies like monoclonal antibodies are employed to neutralize specific toxins, thereby preventing their cytotoxic effects on the host (NEJM, 2017).
Drugs targeting these substances primarily act through physical adsorption, chemical sequestration (binding), or immunological neutralization to prevent the substances from interacting with the intestinal mucosa or being absorbed systemically (StatPearls, 2023; FDA, 2016).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Luminal toxins and harmful substances in the gastrointestinal tract.